ReviewJournal of personalized medicine2026
Prolactin as a Candidate Biomarker in Non-Small Cell Lung Cancer: Implications for Personalized Medicine and Post-Treatment Risk Stratification.
Filip Gajewski et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.